The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Postmarketing Surveillance and Adverse Drug Reactions: Current Perspectives and Future Needs
Abstract
Spontaneous reporting systems like MEDWATCH can be effective in revealing unusual or rare adverse events that occur with the use of medications, and such reports may often be sufficient to assign causality. However, spontaneous reports do not reliably detect adverse drug reactions (ADRs) that occur widely separated in time from the original use of the drug or that represent an increased risk of an adverse event that occurs commonly in populations not exposed to the drug. In these situations, spontaneous reports alone do not provide sufficient evidence to conclude that the adverse event was an ADR. Identification of ADRs associated with long-term administration of drugs for chronic diseases also remains problematic. Methods to evaluate ADRs using data from clinical trials, medical records, and computerized databases of medication users and nonusers must be developed to complement spontaneous reporting systems. Without these methods, potentially important ADRs will remain undetected, and spurious associations between adverse outcomes and medications or devices will remain unchallenged.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Herbst, A. L., Ulfelder, H., & Poskanzer, D. C. (1971) · New England Journal of Medicine · doi:10.1056/nejm197104222841604 · Cited by 2,520
Valvular heart disease associated with fenfluramine-phentermine
Connolly, H. M., Crary, J. L., McGoon, M. D., Hensrud, D. D., Edwards, B. S., Edwards, W. D., & Schaff, H. V. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708283370901 · Cited by 1,632
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322401 · Cited by 1,487
Postmenopausal Hormone Therapy and Mortality
Grodstein, F., Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Joffe, M., Rosner, B., Fuchs, C., Hankinson, S. E., Hunter, D. J., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706193362501 · Cited by 1,184
Self-citationCumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction
Lau, J., Antman, E. M., Jimenez-Silva, J., Kupelnick, B., Mosteller, F., & Chalmers, T. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207233270406 · Cited by 1,140 · cited 1×
“Meta-analysis already has been proposed as a method for determining effectiveness of interventions and therapies.(35) In contrast to the published experience of using meta-analysis to evaluate effectiveness, the use of metaanalysis to assess safety remains limited to date.”
ResultComputerized Surveillance of Adverse Drug Events in Hospital Patients
Classen, D. C. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470200059035 · Cited by 639
Silicone Breast Implants and the Risk of Connective-Tissue Diseases and Symptoms
Sánchez-Guerrero, J., Colditz, G. A., Karlson, E. W., Hunter, D. J., Speizer, F. E., & Liang, M. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322502 · Cited by 364
Self-citationFarrington, P., Rush, M., Miller, E., Pugh, S., Colville, A., Flower, A., Nash, J., & Morgan-Capner, P. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90471-9 · Cited by 338 · cited 2×
“For example, linked vaccination records and hospitalizations were used to assess the risk of convulsions after diphtheria-tetanus-pertussis vaccination and febrile convulsions or idiopathic thrombocytopenia purpura after measles-mumps-rubella vaccination in the United Kingdom.27 Population-based surveillance systems p…”
MethodMeta-analytic Evidence Against Prophylactic Use of Lidocaine in Acute Myocardial Infarction
Hine, L. K. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.12.2694 · Cited by 249
A quantitative assessment of oral contraceptive use and risk of ovarian cancer
Hankinson, S., Colditz, G., Hunter, D., Spencer, T., Rosner, B., & Stampfer, M. (1993) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(93)90732-c · Cited by 206
Self-citationKessler, D. A. (1993) · JAMA · doi:10.1001/jama.1993.03500210065033 · Cited by 194
Temafloxacin Syndrome: Review of 95 Cases
Blum, M. D., Graham, D. J., & McCloskey, C. A. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.6.946 · Cited by 154
The complicated task of monitoring vaccine safety.
Ellenberg, S. S., & Chen, R. T. (1997) · Europe PMC (PubMed Central) · Cited by 138
Scott, H. D. (1990) · JAMA · doi:10.1001/jama.263.13.1785 · Cited by 134
Further Cases of Valvular Heart Disease Associated with Fenfluramine–Phentermine
Graham, D. J., & Green, L. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708283370911 · Cited by 105
Hair Loss After Routine Immunizations
Wise, R. P. (1997) · JAMA · doi:10.1001/jama.1997.03550140068042 · Cited by 101
Stimulating reporting of adverse drug reactions by using a fee.
Feely, J., Moriarty, S., & O'Connor, P. (1990) · BMJ · doi:10.1136/bmj.300.6716.22 · Cited by 94
Muuronen, A., Kaste, M., Nikkilä, E., & Tolppanen, E. ‐. (1985) · BMJ · doi:10.1136/bmj.291.6507.1481 · Cited by 79
Adverse drug reactions: physicians' opinions versus a causality assessment method
Miremont, G., Haramburu, F., B�gaud, B., P�r�, J. C., & Dangoumau, J. (1994) · European Journal of Clinical Pharmacology · doi:10.1007/bf00194392 · Cited by 52
Identification of adverse reactions to new drugs. IV--Verification of suspected adverse reactions.
Venning, G. R. (1983) · BMJ · doi:10.1136/bmj.286.6364.544 · Cited by 50
Brown, R. B., Klar, J., Lemeshow, S., Teres, D., Pastides, H., & Sands, M. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.146.11.2159 · Cited by 49
Exclusion Bias and the False Relationship of Reserpine and Breast Cancer
Horwitz, R. I., & Feinstein, A. R. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.1985.00360100139023 · Cited by 43
Food and Drug Administration monitoring of adverse drug reactions
Sills, J. M., Tanner, L. A., & Milstien, J. B. (1986) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/43.11.2764 · Cited by 32
Does Proof of Causality Ever Exist in Pharmacovigilance?
Auriche, M., & Loupi, E. (1993) · Drug Safety · doi:10.2165/00002018-199309030-00008 · Cited by 25
Feasibility study for identifying adverse events attributable to vaccination by record linkage
Nash, J. Q., Chandrakumar, M., Farrington, P., Williamson, S., & Miller, E. (1995) · Epidemiology and Infection · doi:10.1017/s0950268800052183 · Cited by 17
DEFINING, MONITORING AND COMBINING SAFETY INFORMATION IN CLINICAL TRIALS
Enas, G. G., & GOLDSTEIN, D. J. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140930 · Cited by 16
Anello, C., & O’Neill, R. T. (1996) · Clinical Research and Regulatory Affairs · doi:10.3109/10601339609019625 · Cited by 15
Stolley, P. D. (1982) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1982.tb02642.x · Cited by 11
Active surveillance for vaccine adverse effects
Chen, R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92568-6 · Cited by 1
Cited by
Timing of new black box warnings and withdrawals for prescription medications
Lasser, K. E. (2002) · JAMA · doi:10.1001/jama.287.17.2215 · Cited by 1,005
Infections in patients with rheumatoid arthritis treated with biologic agents
Listing, J., Strangfeld, A., Kary, S., Rau, R., von Hinueber, U., Stoyanova‐Scholz, M., Gromnica‐Ihle, E., Antoni, C., Herzer, P., Kekow, J., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21386 · Cited by 681
Burmester, G. R., Panaccione, R., Gordon, K. B., McIlraith, M. J., & Lacerda, A. P. M. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201244 · Cited by 591
A systematic review and economic evaluation of statins for the prevention of coronary events
Ward, S., Lloyd Jones, M., Pandor, A., Holmes, M., Ara, R., Ryan, A., Yeo, W., & Payne, N. (2007) · Health Technology Assessment · doi:10.3310/hta11140 · Cited by 556
Medicinal properties of Echinacea: A critical review
Barrett, B. (2003) · Phytomedicine · doi:10.1078/094471103321648692 · Cited by 470
Metadata
- Authors
- Brewer, T., & Colditz, G. A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1999-03-03
- Volume
- 281
- Issue
- 9
- Pages
- 824
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1989269439
- Cited by
- 327
- References
- 29
- FWCI
- 23.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.